FDA Announces Public Hearing to Inform Regulatory Next Steps

HomeLegal Updates

By: Vorys, Sater, Seymour and Pease LLP.

On April 3, 2019, the federal Food and Drug Administration (FDA) published a notice in the Federal Register announcing a public hearing and related comment period regarding stakeholders’ experience with products containing the cannabis derivative cannabidiol, popularly known as “CBD.” Read more.

MORE...